Purpose of Review: The goal of this paper is to provide a comprehensive review of the management options for central serous chorioretinopathy (CSCR). Recent Findings: The majority of cases of acute CSCR may be managed with observation and cessation of corticosteroids, if possible, as well as lifestyle modifications including stress reduction and control of hypertension. The management of chronic disease is more challenging and may include either medication or laser-based treatment. Summary: Management of CSCR necessitates an individualized and selective treatment approach. There is overall poor evidence for the use of systemic and intravitreal medications. From this class of treatments, mineralocorticoid receptor antagonists appear to have the greatest potential. Although conventional thermal photocoagulation may be used in select cases, the most promising treatment options at this time for chronic CSCR are photodynamic therapy, either half-dose or half-fluence, and non-damaging (subthreshold) retinal laser therapy.
- Central serous chorioretinopathy
- Central serous retinopathy
- Photodynamic therapy
- Subthreshold laser
ASJC Scopus subject areas